litlas
ログインアカウント作成

Katherine A. High

1989–2025 年に発表

111
論文数
35,185
被引用数
91
h 指数
110
i10 指数

被引用数

Katherine A. High の年別被引用数1990 年: 被引用 2 件1991 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 2 件1995 年: 被引用 3 件1996 年: 被引用 4 件1997 年: 被引用 23 件1998 年: 被引用 76 件1999 年: 被引用 101 件2000 年: 被引用 121 件2001 年: 被引用 141 件2002 年: 被引用 135 件2003 年: 被引用 161 件2004 年: 被引用 134 件2005 年: 被引用 150 件2006 年: 被引用 174 件2007 年: 被引用 159 件2008 年: 被引用 239 件2009 年: 被引用 260 件2010 年: 被引用 256 件2011 年: 被引用 296 件2012 年: 被引用 306 件2013 年: 被引用 391 件2014 年: 被引用 371 件2015 年: 被引用 347 件2016 年: 被引用 282 件2017 年: 被引用 543 件2018 年: 被引用 430 件2019 年: 被引用 1,238 件2020 年: 被引用 1,583 件2021 年: 被引用 1,376 件2022 年: 被引用 1,068 件2023 年: 被引用 921 件2024 年: 被引用 1,203 件2025 年: 被引用 682 件2026 年: 被引用 10 件1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,288 件、この内訳の 36.1%中国: 引用元論文 795 件、この内訳の 8.7%イギリス: 引用元論文 662 件、この内訳の 7.3%ドイツ: 引用元論文 483 件、この内訳の 5.3%フランス: 引用元論文 431 件、この内訳の 4.7%イタリア: 引用元論文 354 件、この内訳の 3.9%カナダ: 引用元論文 271 件、この内訳の 3%オランダ: 引用元論文 247 件、この内訳の 2.7%オーストラリア: 引用元論文 231 件、この内訳の 2.5%日本: 引用元論文 215 件、この内訳の 2.4%スペイン: 引用元論文 211 件、この内訳の 2.3%スイス: 引用元論文 167 件、この内訳の 1.8%
0%36.1%その他 19.3%

機関

分野

  • Biochemistry, Genetics and Molecular Biology68.7%
  • Medicine22.3%
  • Neuroscience3.8%
  • Immunology and Microbiology1.6%
  • Engineering1.5%
  • Materials Science0.8%
  • その他1.3%

トピック

  • Virus-based gene therapy research14.7%
  • CRISPR and Genetic Engineering8.6%
  • RNA Interference and Gene Delivery7.6%
  • Retinal Development and Disorders5.9%
  • CAR-T cell therapy research4%
  • Viral Infectious Diseases and Gene Expression in Insects3.3%
  • その他55.9%

共著者

全論文

検索で開く
  1. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial

    著者: Stephen R. Russell, Jean Bennett, Jennifer Wellman, Daniel C. Chung, Zi-Fan Yu, Amy Tillman, Janet Wittes, Julie Pappas, Okan U. Elci, Sarah McCague, Dominique Cross, Kathleen Marshall, Jean Walshire, Taylor Kehoe, Hannah Reichert, Maria Davis, Leslie Raffini, Lindsey A. George, Fleur Hudson, Laura Dingfield, Xiaosong Zhu, Julia A. Haller, Elliott H. Sohn, Vinit B. Mahajan, Wanda Pfeifer, Michelle T. Weckmann, Chris A. Johnson, Dina Y. Gewaily, Arlene V. Drack, Edwin M. Stone, Katie Wachtel, Francesca Simonelli, Bart P. Leroy, J. Fraser Wright, Katherine A. High, Albert M. Maguire - The Lancet 2017 被引用: 1,889

  2. Gene therapy comes of age

    著者: Cynthia E. Dunbar, Katherine A. High, J. Keith Joung, Donald B. Kohn, Keiya Ozawa, Michel Sadelain - Science 2018 被引用: 1,378

  3. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

    著者: Catherine S. Manno, Glenn F. Pierce, Valder R. Arruda, Bertil Glader, Margaret V. Ragni, John E.J. Rasko, Margareth C. Ozelo, Keith Hoots, Philip M. Blatt, Barbara A. Konkle, Michael D. Dake, Robin Kaye, Mahmood Razavi, Albert Zajko, James L. Zehnder, Pradip K. Rustagi, Hiroyuki Nakai, Amy Chew, Debra G. B. Leonard, J Fraser Wright, Ruth Lessard, Jürg M. Sommer, Michael Tigges, Denise E. Sabatino, Alvin Luk, Haiyan Jiang, Federico Mingozzi, Linda Couto, Hildegund C.J. Ertl, Katherine A. High, Mark A. Kay - Nature Medicine 2006 被引用: 2,135

  4. Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B

    著者: Amit C. Nathwani, Edward G. D. Tuddenham, Savita Rangarajan, Cecilia Rosales, Jenny McIntosh, David C. Linch, Pratima Chowdary, Anne Riddell, Arnulfo Pie, Chris F. Harrington, James O’Beirne, Keith Smith, John Pasi, Bertil Glader, Pradip K. Rustagi, Catherine Y. Ng, Mark A. Kay, Junfang Zhou, Yunyu Spence, Christopher L. Morton, James A. Allay, John B. Coleman, Susan Sleep, John M. Cunningham, Deo Kumar Srivastava, Etiena Basner‐Tschakarjan, Federico Mingozzi, Katherine A. High, John T. Gray, Ulrike M. Reiss, Arthur W. Nienhuis, Andrew M. Davidoff - New England Journal of Medicine 2011 被引用: 1,843

  5. Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B

    著者: Amit Nathwani, Ulreke M. Reiss, Edward G. D. Tuddenham, Cecilia Rosales, Pratima Chowdary, Jenny McIntosh, Marco Della Peruta, Elsa Lhériteau, Nishal Patel, Deepak B. Thimiri Govinda Raj, Anne Riddell, Jun Pie, Savita Rangarajan, David Bevan, Michael Recht, Yu‐Min Shen, Kathleen G. Halka, Etiena Basner‐Tschakarjan, Federico Mingozzi, Katherine A. High, James A. Allay, Mark A. Kay, Catherine Y. Ng, Junfang Zhou, Maria Cancio, Christopher L. Morton, John T. Gray, Deo Kumar Srivastava, Arthur W. Nienhuis, Andrew M. Davidoff - New England Journal of Medicine 2014 被引用: 1,250

  6. Immune responses to AAV vectors: overcoming barriers to successful gene therapy

    著者: Federico Mingozzi, Katherine A. High - Blood 2013 被引用: 920

  7. Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant

    著者: Lindsey A. George, Spencer K. Sullivan, Adam Giermasz, John E.J. Rasko, Benjamin J. Samelson‐Jones, Jonathan M. Ducore, Adam Cuker, Lisa Sullivan, Suvankar Majumdar, Jerome Teitel, Catherine McGuinn, Margaret V. Ragni, Alvin Luk, Daniel J. Hui, J. Fraser Wright, Yifeng Chen, Yun Liu, Katie Wachtel, Angela Winters, Stefan Tiefenbacher, Valder R. Arruda, Johannes C.M. van der Loo, Olga Zelenaia, Daniel M. Takefman, Marcus E. Carr, Linda B. Couto, Xavier M. Anguela, Katherine A. High - New England Journal of Medicine 2017 被引用: 759

  8. Gene Therapy

    著者: Katherine A. High, Maria Grazia Roncarolo - New England Journal of Medicine 2019 被引用: 525

  9. Entering the Modern Era of Gene Therapy

    著者: Xavier M. Anguela, Katherine A. High - Annual Review of Medicine 2018 被引用: 468

  10. Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy

    著者: Albert M. Maguire, Stephen R. Russell, Jennifer Wellman, Daniel C. Chung, Zi‐Fan Yu, Amy Tillman, Janet Wittes, Julie Pappas, Okan U. Elci, Kathleen Marshall, Sarah McCague, Hannah Reichert, Maria Davis, Francesca Simonelli, Bart P. Leroy, J. Fraser Wright, Katherine A. High, Jean Bennett - Ophthalmology 2019 被引用: 391

  11. Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis

    著者: Albert M. Maguire, Francesca Simonelli, Eric A. Pierce, Edward N. Pugh, Federico Mingozzi, Jeannette Bennicelli, Sandro Banfi, Kathleen Marshall, Francesco Testa, Enrico Maria Surace, Settimio Rossi, Arkady Lyubarsky, Valder R. Arruda, Barbara A. Konkle, Edwin M. Stone, Junwei Sun, Jonathan B. Jacobs, Lou F Dell'Osso, Richard W. Hertle, Jian‐xing Ma, T. Michael Redmond, Xiaosong Zhu, Bernd Hauck, Olga Zelenaia, Kenneth S. Shindler, Maureen G. Maguire, J. Fraser Wright, Nicholas J. Volpe, Jennifer Wellman McDonnell, Alberto Auricchio, Katherine A. High, Jean Bennett - New England Journal of Medicine 2008 被引用: 2,137

  12. CD8+ T-cell responses to adeno-associated virus capsid in humans

    著者: Federico Mingozzi, Marcela V. Maus, Daniel J. Hui, Denise E. Sabatino, Samuel L. Murphy, John E.J. Rasko, Margaret V. Ragni, Catherine S. Manno, Jürg M. Sommer, Haiyan Jiang, Glenn F. Pierce, Hildegund C.J. Ertl, Katherine A. High - Nature Medicine 2007 被引用: 726

  13. Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

    著者: Lindsey A. George, Paul E. Monahan, M. Elaine Eyster, Spencer K. Sullivan, Margaret V. Ragni, Stacy E. Croteau, John E.J. Rasko, Michael Recht, Benjamin J. Samelson‐Jones, Amy MacDougall, Kristen Jaworski, Robert Noble, Marla Curran, Klaudia Kuranda, Federico Mingozzi, Tiffany Chang, Kathleen Z. Reape, Xavier M. Anguela, Katherine A. High - New England Journal of Medicine 2021 被引用: 253

  14. Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B

    著者: Lindsey A. George, Margaret V. Ragni, John E.J. Rasko, Leslie Raffini, Benjamin J. Samelson‐Jones, Margareth C. Ozelo, Maria Hazbon, Alexa R. Runowski, Jennifer Wellman, Katie Wachtel, Yifeng Chen, Xavier M. Anguela, Klaudia Kuranda, Federico Mingozzi, Katherine A. High - Molecular Therapy 2020 被引用: 209

  15. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

    著者: Albert M. Maguire, Katherine A. High, Alberto Auricchio, J. Fraser Wright, Eric A. Pierce, Francesco Testa, Federico Mingozzi, Jeannette Bennicelli, Gui‐Shuang Ying, Settimio Rossi, Ann Fulton, Kathleen Marshall, Sandro Banfi, Daniel C. Chung, Jessica I. W. Morgan, Bernd Hauck, Olga Zelenaia, Xiaosong Zhu, Leslie Raffini, Frauke Coppieters, Elfride De Baere, Kenneth S. Shindler, Nicholas J. Volpe, Enrico Maria Surace, Carmela Acerra, Arkady Lyubarsky, T. Michael Redmond, Edwin M. Stone, Junwei Sun, Jennifer Wellman McDonnell, Bart P. Leroy, Francesca Simonelli, Jean Bennett - The Lancet 2009 被引用: 858

  16. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges

    著者: Federico Mingozzi, Katherine A. High - Nature Reviews Genetics 2011 被引用: 901

  17. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial

    著者: Jean Bennett, Jennifer Wellman, Kathleen Marshall, Sarah McCague, Manzar Ashtari, Julie DiStefano‐Pappas, Okan U. Elci, Daniel C. Chung, Junwei Sun, J. Fraser Wright, Dominique Cross, Puya Aravand, Laura Cyckowski, Jeannette Bennicelli, Federico Mingozzi, Alberto Auricchio, Eric A. Pierce, Jason Ruggiero, Bart P. Leroy, Francesca Simonelli, Katherine A. High, Albert M. Maguire - The Lancet 2016 被引用: 456

  18. Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease

    著者: Albert M. Maguire, Stephen R. Russell, Daniel C. Chung, Zi‐Fan Yu, Amy Tillman, Arlene V. Drack, Francesca Simonelli, Bart P. Leroy, Kathleen Z. Reape, Katherine A. High, Jean Bennett - Ophthalmology 2021 被引用: 188

  19. Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys

    著者: Federico Mingozzi, Xavier M. Anguela, Giulia Pavani, Yifeng Chen, Robert J. Davidson, Daniel J. Hui, Mustafa N. Yazicioglu, Liron Elkouby, Christian Hinderer, Armida Faella, Carolann Howard, Alex Tai, Gregory M. Podsakoff, Shangzhen Zhou, Etiena Basner‐Tschakarjan, J. Fraser Wright, Katherine A. High - Science Translational Medicine 2013 被引用: 344

  20. Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy

    著者: Haiyan Jiang, Linda B. Couto, Susannah Patarroyo‐White, Tongyao Liu, Dea Nagy, Joseph Vargas, Shangzhen Zhou, Ciaran D. Scallan, Jürg M. Sommer, Sharmila Vijay, Federico Mingozzi, Katherine A. High, Glenn F. Pierce - Blood 2006 被引用: 320

  21. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B

    著者: Catherine S. Manno, Ah Keng Chew, S Hutchison, Peter J. Larson, Roland W. Herzog, V. R. Arruda, Shing Jen Tai, Margaret V. Ragni, Alexis A. Thompson, Margareth C. Ozelo, Linda B. Couto, Debra G. B. Leonard, Freddie A. Johnson, Alan McClelland, Ciaran D. Scallan, Erik D. Skarsgard, Alan W. Flake, Mark A. Kay, Katherine A. High, Bertil Glader - Blood 2003 被引用: 747

  22. AAV-1–mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells

    著者: Federico Mingozzi, J. J. M. Meulenberg, Daniel J. Hui, Etiena Basner‐Tschakarjan, Nicole C. Hasbrouck, Shyrie Edmonson, Natalie A. Hutnick, Michael R. Betts, John J.P. Kastelein, Erik S.G. Stroes, Katherine A. High - Blood 2009 被引用: 284

  23. Clinical development of gene therapy: results and lessons from recent successes

    著者: Sandeep Kumar, David M. Markusic, Moanaro Biswas, Katherine A. High, Roland W. Herzog - Molecular Therapy — Methods & Clinical Development 2016 被引用: 229

  24. Assessing the potential for AAV vector genotoxicity in a murine model

    著者: Hojun Li, Nirav Malani, Shari R Hamilton, Alexander Schlachterman, Giulio Bussadori, Shyrie E. Edmonson, Rachel Shah, Valder R. Arruda, Federico Mingozzi, J. Fraser Wright, Frederic D. Bushman, Katherine A. High - Blood 2010 被引用: 228